Co-Authors
This is a "connection" page, showing publications co-authored by Emmanuel Favaloro and Brandon Henry.
Connection Strength
2.553
-
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? Semin Thromb Hemost. 2022 Feb; 48(1):72-92.
Score: 0.238
-
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature. Semin Thromb Hemost. 2022 Feb; 48(1):55-71.
Score: 0.238
-
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients. Clin Chem Lab Med. 2021 10 26; 59(11):e413-e415.
Score: 0.238
-
The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19. Int J Lab Hematol. 2021 Aug; 43(4):547-558.
Score: 0.236
-
Mean Platelet Volume Predicts Severe COVID-19 Illness. Semin Thromb Hemost. 2021 06; 47(4):456-459.
Score: 0.235
-
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis. Semin Thromb Hemost. 2021 Jun; 47(4):400-418.
Score: 0.235
-
Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study. Semin Thromb Hemost. 2021 06; 47(4):451-455.
Score: 0.231
-
ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy. Int J Lab Hematol. 2021 Jul; 43 Suppl 1:129-136.
Score: 0.229
-
Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc. 2021 01; 96(1):203-217.
Score: 0.228
-
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost. 2020 10; 46(7):859-862.
Score: 0.225
-
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020 Aug; 507:167-173.
Score: 0.220